Michael Weisman
Overview
Explore the profile of Michael Weisman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1787
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weisman M, McClelland 3rd S, Agrawal N, Jimenez R, Yechieli R, Fields E, et al.
Adv Radiat Oncol
. 2025 Feb;
10(1):101627.
PMID: 40017913
Checklists have been used across many fields as a systematic framework to reduce human error and improve safety. In radiation oncology, the CB-CHOP acronym was previously developed as a tool...
2.
Weisman M, Durm G, Shields M, Hanna N, Althouse S, Lautenschlaeger T
Int J Radiat Oncol Biol Phys
. 2024 Nov;
121(3):720-727.
PMID: 39490906
Purpose: The addition of immunotherapy (IO) after concurrent chemoradiation therapy (CCRT) for unresectable non-small cell lung cancer (NSCLC) has become common practice in eligible patients. Approaches to further improve outcomes...
3.
Azizoddin D, Olmstead R, Anderson K, Hirz A, Irwin M, Gholizadeh S, et al.
BMC Rheumatol
. 2024 Sep;
8(1):46.
PMID: 39304956
Background: Guided by the reserve capacity model, we evaluated the unique relationships between socioeconomic status (SES), reserve capacity (helplessness, self-efficacy, social support), and negative emotions on pain in patients with...
4.
Simard J, Liu E, Rector A, Cantu M, Chakravarty E, Druzin M, et al.
Arthritis Care Res (Hoboken)
. 2024 Jun;
76(10):1390-1395.
PMID: 38926748
Objective: Patients with systemic lupus erythematosus (SLE) are at risk for pregnancy complications such as pre-eclampsia and eclampsia. These clinically important complications are associated with maternal morbidity, mortality, and postpartum...
5.
Delgado M, Rodman J, Xepoleas M, Weisman M, Wise L
Lupus Sci Med
. 2024 Feb;
11(1).
PMID: 38382933
Objective: Management of reproductive health-related issues is crucial for patients with SLE, given this is a disease that primarily affects women of childbearing age. Little is known as to how...
6.
Horisberger A, Griffith A, Keegan J, Arazi A, Pulford J, Murzin E, et al.
bioRxiv
. 2024 Jan;
PMID: 38293222
Lupus nephritis (LN) is a frequent manifestation of systemic lupus erythematosus, and fewer than half of patients achieve complete renal response with standard immunosuppressants. Identifying non-invasive, blood-based pathologic immune alterations...
7.
Azizoddin D, Olmstead R, Anderson K, Hirz A, Irwin M, Gholizadeh S, et al.
Res Sq
. 2023 Apr;
PMID: 37066198
Background: Guided by the reserve capacity model, we examined the roles of socioeconomic status (SES), reserve capacity, and negative emotions as determinants of pain in patients with Rheumatoid Arthritis (RA)....
8.
Giaconi J, Waldman L, Robinson J, Milanovic N, Weisman M, Learch T
Skeletal Radiol
. 2021 Aug;
51(4):795-799.
PMID: 34398309
Objective: To determine the prevalence of sacroiliitis among patients who have been referred for MR arthrography. Materials And Methods: A retrospective search identified 130 consecutive MR arthrograms of the hip...
9.
Jolly M, Sehgal V, Arora S, Azizoddin D, Pinto B, Sharma A, et al.
Lupus
. 2021 Jul;
30(11):1790-1798.
PMID: 34304629
Background: Hydroxychloroquine (HCQ) use is associated with less disease activity, flares, damage and improved survival in Systemic Lupus Erythematosus (SLE). However, its effect on patient reported health outcomes (PROs) such...
10.
Skaggs B, Grossman J, Sahakian L, Perry L, FitzGerald J, Charles-Schoeman C, et al.
ACR Open Rheumatol
. 2021 Feb;
3(4):209-220.
PMID: 33605563
Objective: The increase in cardiovascular events (CVEs) in systemic lupus erythematosus (SLE) is not fully explained by traditional risk factors. We previously identified four biomarkers (proinflammatory high-density lipoprotein, leptin, soluble...